Although inhibition of ERK5 is a potent strategy to kill cancer cells, ERK5 kinase inhibitors often fail to recapitulate ERK5 genetic ablation phenotypes, and the efficiency is comprised in cancer cells [17]. The gene discussed is MAPK7; the disease is cancer.